Baxter price target raised to $58 from $54 at Barclays

Barclays analyst Matt Miksic raised the firm’s price target on Baxter to $58 from $54 and keeps an Overweight rating on the shares. The Q1 beat propelled Baxter over an "important hurdle and set it on course to regain investor confidence," the analyst tells investors in a research note.